News of Note—Russian trolls, AstraZeneca's FluMist and more


Here is some other vaccine news of note for the week:

> Russian trolls and social media bots used Twitter to spread false information about vaccines ahead of the 2016 U.S. presidential election, a new study found. Release

> The CDC endorsed AstraZeneca's FluMist for the upcoming flu season after recommending against its use for the two prior seasons. A committee recommended the nasal vaccine for the upcoming season in February. CIDRAP News article

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> After health officials decided pregnant women shouldn't receive an experimental Ebola vaccine during an outbreak in the Democratic Republic of Congo, experts wrote an editorial in Stat calling for a reversal of the decision. Stat editorial


Suggested Articles

The company aims to enter the clinic with a pan-flavivirus vaccine against Zika, dengue and yellow fever in 2019.

Here is some other vaccine news of note for the week.

Sanofi has faced more than a year of controversy for its dengue vaccine, and now Philippine officials have revoked Dengvaxia's regulatory approval.